tiprankstipranks
Neumora Therapeutics, Inc. (NMRA)
NASDAQ:NMRA
US Market

Neumora Therapeutics, Inc. (NMRA) Income Statement

Compare
271 Followers

Neumora Therapeutics, Inc. Income Statement

Last quarter (Q3 2024), Neumora Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Neumora Therapeutics, Inc.'s net income was $-72.55M. See Neumora Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -668.00K$ -2.70M$ -1.55M$ 0.00
Operating Expenses
$ 187.53M$ 135.87M$ 237.32M$ 95.52M
Depreciation and Amortization
$ 668.00K$ 2.70M$ 1.55M$ 105.00K
EBITDA
$ -187.53M$ -135.28M$ -236.78M$ -95.41M
Operating Income
$ -188.19M$ -135.87M$ -237.32M$ -95.52M
Other Income/Expenses
$ -47.46M$ 4.97M$ 11.00K$ -3.75M
Pretax Income
$ -235.66M$ -130.90M$ -237.31M$ -99.27M
Net Income
$ -235.93M$ -130.90M$ -237.31M$ -99.27M
Per Share Metrics
$ ―$ ―$ ―$ ―
Basic EPS
$ -1.49$ -0.86$ -1.56$ -0.65
Diluted EPS
$ -1.49$ -0.86$ -1.56$ -0.65
Weighted Average Shares Outstanding
158.83M 151.95M 151.95M 151.95M
Weighted Average Shares Outstanding (Diluted)
158.83M 151.95M 151.95M 151.95M
Currency in USD

Neumora Therapeutics, Inc. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis